However, while this dual mechanism of drug delivery and ROS-generation enhances antitumour efficacy, the potential for off-target oxidative damage to healthy brain cells and associated neurotoxicity was not comprehensively evaluated, which may in-turn limit translational interpretation
found that four weeks of IGF-1 treatment (~2 mg/kg body mass, 50 g/h delivered subcutaneously by a miniosmotic pump) increased the mass and force-producing limit of SM from dystrophic mice
The evidence that COVID-19 does not worsen after treatment with plasma from convalescent patients has been substantially reinforced by a study of 20,000 patients who were severely ill with the disease, showing an adverse event incidence of 13% 81
It has demonstrated potential benefits in protecting and repairing damaged heart tissue, improving cardiac function, and enhancing angiogenesis
doi: 10.1038/s42003-025-07541-x 142